X-Chem Montreal specializes in identifying small molecule novel leads and optimizing them as successful clinical candidates. Our expertise in medicinal chemistry, synthesis and process chemistry allows us to drive all aspects of drug research. Our research scientists are responsible for more than 100 patents, 17 compounds advancing to the IND stage, and 8 compounds that have reached Phase 1 clinical trials or beyond. For more information,  read our booklet!